ArticleBMC cancer2025

A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41.

Zihan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.